SaudiVax, located in the KAUST Research & Technology Park, is collaborating with the University of Pittsburgh and Merck France to develop a COVID-19 antibody injection. The antibody both protects against potential infection and neutralizes the virus in those already infected. SaudiVax is utilizing KAUST expertise and has contracted with Merck France for manufacturing since suitable facilities are not yet available in Saudi Arabia. Why it matters: This partnership highlights the growing biopharmaceutical capabilities in Saudi Arabia and the potential for KAUST to serve as a hub for medical innovation in the region.
Jasmeen Merzaban, a KAUST assistant professor of bioscience, received a L'Oréal-UNESCO For Women in Science International Rising Talents award at a ceremony in Paris on March 24. Merzaban's research focuses on immunology and stem cell research. The award recognizes her contributions to science and potential for future impact. Why it matters: This award highlights the growing scientific expertise and recognition of researchers at KAUST and in Saudi Arabia.
KAUST Professor Pierre Magistretti participated in the U.S.-Saudi Arabia Business Leaders Virtual Forum, organized by the U.S. Chamber of Commerce and the Saudi Ministry of Investment. Magistretti spoke on a panel about healthcare innovation alongside representatives from Pfizer, Abbott, and the Saudi Ministry of Investment. KAUST's Smart-Health Initiative (SHI) aims to translate scientific discoveries into clinical tools. Why it matters: This participation highlights KAUST's growing role in shaping healthcare innovation within the Kingdom and fostering international collaborations in the field.
Agathe Guilloux, a professor in Data Science at Evry Paris Saclay University, presented on machine learning algorithms for precision medicine at MBZUAI. Her talk covered the main challenges of precision medicine and how AI can address them. She also discussed algorithms developed for decision support tools. Why it matters: This highlights MBZUAI's role as a platform for discussing advanced AI applications in healthcare, even when the research is not directly conducted in the GCC.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.
Jean M. J. Fréchet, retired KAUST senior vice president, has been awarded the King Faisal Prize in Chemistry for his pioneering work in dendrimers, photoresists, and organic photovoltaics. His work has contributed to advancements in biotherapeutics, organic electronics, materials, and microfluidics. Fréchet is the 10th most cited chemist globally, with over 900 publications and 200 patents. Why it matters: The recognition highlights KAUST's impact on global scientific advancement and underscores the importance of investing in basic research with broad applications.
KAUST and Bruker Corporation have launched the KAUST–Bruker Center of Excellence (CoE) in Magnetic Resonance, formalizing a long-standing collaboration. The CoE will provide KAUST users access to cutting-edge magnetic resonance technologies and serve as a training site. Bruker showcased advanced technologies including the world's first 900 MHz wide-bore NMR spectrometer and a 500 MHz super wide-bore MRI spectrometer. Why it matters: This CoE enhances KAUST's position as a leading research institution in the region and fosters innovation in magnetic resonance research and applications.
KAUST held a research conference on polymers, focusing on designing macromolecules for applications. The conference featured opening remarks from KCC director Jean-Marie Basset and presentations from professors including Nikos Hadjichristidis, Robert Waymouth, Natalie Stingelin, and Ingo Pinnau. Pinnau discussed the role of the KAUST Advanced Membranes & Porous Materials Center (AMPMC). Why it matters: The conference highlights KAUST's focus on advanced materials research and its contribution to scientific advancements in polymer science.